ZIOPHARM Oncology Inc (ZIOP) Given Average Rating of "Hold" by Analysts

ZIOPHARM Oncology Inc (ZIOP) Given Average Rating of "Hold" by Analysts


ZIOPHARM Oncology Inc has been assigned a consensus rating of "Hold" from the seven analysts that are presently covering the stock. One analyst has rated the stock with a sell rating, four have issued a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company.



from Biotech News